A flexible blueprint for the future of drug development

被引:15
作者
Barker, Richard [1 ]
机构
[1] Assoc British Pharmaceut Ind, London SW1A 2DY, England
关键词
D O I
10.1016/S0140-6736(10)60141-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:357 / 359
页数:3
相关论文
共 5 条
[1]  
[Anonymous], CRIT PATH IN
[2]  
Berry D.A., 1996, Bayesian Biostatistics
[3]  
Cooksey D., 2006, REV UK HLTH RES FUND
[4]   Risks in new drug development: Approval success rates for investigational drugs [J].
DiMasi, JA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (05) :297-307
[5]   De testimonio: on the evidence for decisions about the use of therapeutic interventions [J].
Rawlins, Michael .
LANCET, 2008, 372 (9656) :2152-2161